Start free

PolicyChanges tracks payer policy changes for medical practices and tells you what to do before they take effect.

Create a free accountPolicy Monitoring is free. No card required.
← Back to list
Independence Blue CrossCommercial · Administrative · Medical Policy · Allergy & Immunology, Hematology, Infectious Disease +4 moreLow impact

08.00.13ao, Immune Globulin Intravenous (IVIG), Subcutaneous (SCIG)

Effective date
Jul 1, 2026
Identified
Oct 29, 2026

Summary

Independence Blue Cross reissued medical policy 08.00.13ao for IVIG/SCIG on 07/01/2026 with no material changes to coverage criteria or medical necessity indications. The only revision was a minor HCPCS code narrative update to J1569 to add 'gammagard liquid erc' as an example product. This is an administrative reissuance per annual review process; no billing workflow changes are required.

Get alerts when payers change rules like this one

We check Independence Blue Cross and other payers every day and email you when a change matches your specialty and state.

Get Independence Blue Cross alertsPolicy Monitoring is free. No card required.

What to do

Action · 5 steps
01No immediate action required.
02The policy effective date of 07/01/2026 is already in the past (analysis date 2026-10-29).
03Verify that the practice's billing system reflects the current HCPCS code descriptions for J1569, which now includes 'gammagard liquid/gammagard liquid erc' in the product narrative.
04No changes to prior authorization requirements, medical necessity criteria, or covered indications were made in this reissuance.
05Confirm current applicability by reviewing the full policy at the source URL if questions arise about IVIG/SCIG coverage for specific patient diagnoses.

Codes mentioned

J1555J1558J1559J1561J1569J1575

Original notice

08.00.13ao, Immune Globulin Intravenous (IVIG), Subcutaneous (SCIG)
medpolicy.ibx.com · Always check the source before changing claims.
View original ↗

Related changes

See all Independence Blue Cross changes →
MA08.009z, Immune Globulin Intravenous (IVIG), Subcutaneous (SCIG)LowEffective Jul 1, 2026 · Medical PolicyMA08.009w, Immune Globulin Intravenous (IVIG), Subcutaneous (SCIG)MediumEffective Jan 1, 2025 · Medical PolicyMA08.009y, Immune Globulin Intravenous (IVIG), Subcutaneous (SCIG)MediumEffective Apr 1, 2026 · Medical Policy08.00.13al, Immune Globulin Intravenous (IVIG), Subcutaneous (SCIG)MediumEffective Oct 1, 2025 · Medical PolicyBrowse every Independence Blue Cross change in the policy list

Related policy hubs

Independence Blue Cross policiesAllergy & ImmunologyHematologyInfectious DiseaseNeurologyOncologyDermatologyPharmacyCode J1555Code J1558Code J1559Code J1561Code J1569Code J1575

Summaries are AI-assisted. Always confirm against the original payer notice.

What is PolicyChanges

One workspace for payer rules, prior auth, coding and compliance

Medical practices use PolicyChanges to catch payer changes before they cause denials. Every change is summarized in plain English, with the codes involved, the date it takes effect and what to do.

Policy MonitoringPayer policy, prior auth and coding changes, filtered to your saved searchesOIG ScreeningStaff and vendors screened every month against OIG LEIE, SAM.gov and state Medicaid listsPrior Auth LookupKnow if a service needs prior authorization before you schedule itCredentialing TrackerLicenses, CAQH, Medicare revalidation and payer enrollments, with reminders before anything lapsesCompliance CenterKeep your HIPAA program documented and ready to show
Start freePolicy Monitoring is free. No card required.
Get alerts for changes like thisPolicy Monitoring is free. No card required.Create a free account